
No Priors: Artificial Intelligence | Technology | Startups
Powering AI-Driven Drug Discovery with President of Isomorphic Labs Max Jaderberg
Listen to the full episodeDo not have it yet? Parasocial is a podcast player by Super Simple.

No Priors: Artificial Intelligence | Technology | Startups
Do not have it yet? Parasocial is a podcast player by Super Simple.
Drug discovery and development has long relied on expensive, time-consuming empirical trial and error. By shifting the discovery process onto computers, Isomorphic Labs wants to fundamentally change medicine from a process of discovery to one of precision engineering. Elad Gil sits down with Isomorphic’s president Max Jaderberg to discuss his vision for using predictive AI models to achieve experimental accuracy. Max details how the success of AlphaFold provided the first proof of concept that a deep learning model could generalize in the field of biology, and how an AI model’s compounding of learnings allows it to achieve generalizability with scale, thus greatly increasing the probability of success as well as speed in real world clinical trials. He also talks about evolving past the need for animal testing through in-silico models, Isomorphic’s focus on developing drug design engines that are agnostic of disease area, target class, and modality, why accurate molecule engineering unlocks the potential for multidrug cocktails that span complex biological pathways, and how he believes AI molecule optimization will improve both human lifespan and healthspan. Sign up for new podcast